Clinical Trials
4 trialsNCT07603791 2026-05-22
Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 2 Not yet recruiting
NCT07591090 2026-05-15
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
Akeso
Phase 2 Not yet recruiting
NCT07586124 2026-05-14
Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
Lepu Biopharma Co., Ltd.
Phase 2 Not yet recruiting
NCT07564466 2026-05-11
A Study of SKB571 in Participants With Gastrointestinal Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2 Not yet recruiting